London—Dentons has advised Astorg, a leading private equity group, on its acquisition of a majority stake in Avania from Kester Capital. Kester Capital retains a minority stake.

Avania is one of the leading global providers of outsourced clinical trial services specifically focused on medical technology, covering the full regulatory lifecycle across a broad range of therapeutic areas. Headquartered in the Netherlands, and with eight offices across North America, Europe and Asia Pacific, Avania serves 300 medical device original equipment manufacturers (OEMs) of different sizes through an integrated service offering including clinical trial management, biostatistics, regulatory consulting, data analytics, medical writing and reimbursement.

Astorg’s investment will enable Avania to continue expanding its service offering and geographic coverage, while actively executing M&A opportunities in a fragmented market.

The Dentons cross-border team advising Astorg was led from the UK by Corporate partner Stephen Levy with support from Corporate partners James Davison and Adam Knowles, Corporate counsel Michael Snook, Corporate senior associate Rachael Del Riccio, Corporate associates Vincent Leung and Elijah Smith and Corporate trainee Katie Henson. The Dentons team in the Netherlands included Corporate partner Kuif Klein Wassink, Tax partner Marnix Veldhuijzen and Corporate counsel Bram Bloemers.

About Dentons

Across over 80 countries, Dentons helps you grow, protect, operate and finance your organization by providing uniquely global and deeply local legal solutions. Polycentric, purpose-driven and committed to inclusion, diversity, equity and sustainability, we focus on what matters most to you. www.dentons.com